Unknown

Dataset Information

0

Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.

ABSTRACT: This corrects the article DOI: 10.1038/ncomms14454.

SUBMITTER: Bengtsson NE 

PROVIDER: S-EPMC5489999 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.

Bengtsson Niclas E NE   Hall John K JK   Odom Guy L GL   Phelps Michael P MP   Andrus Colin R CR   Hawkins R David RD   Hauschka Stephen D SD   Chamberlain Joel R JR   Chamberlain Jeffrey S JS  

Nature communications 20170623

This corrects the article DOI: 10.1038/ncomms14454. ...[more]

Similar Datasets

Unknown Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.
| S-EPMC5316861 | biostudies-literature
Unknown Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.
| S-EPMC4335351 | biostudies-literature
Unknown CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy.
| S-EPMC9294086 | biostudies-literature
Unknown Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy.
| S-EPMC6205228 | biostudies-literature
Unknown Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy.
| S-EPMC5451761 | biostudies-literature
Unknown CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy.
| S-EPMC8828535 | biostudies-literature
Unknown A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing.
| S-EPMC9398917 | biostudies-literature
Unknown Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening.
| S-EPMC8440673 | biostudies-literature
Unknown Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy.
| S-EPMC6455975 | biostudies-literature
Unknown Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy.
| S-EPMC8995704 | biostudies-literature